[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,579
Sort by:

Coagulation Factor VIII (Antihemophilic Factor or AHF or Procoagulant Component or F8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Coagulation Factor VIII (Antihemophilic Factor or AHF or Procoagulant Component or F8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Co...

May 2022 82 pages

Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21.6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21.6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Coagul...

May 2022 59 pages

Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Coagulation Factor...

May 2022 40 pages

Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 144 pages

Collagen Alpha 1(VII) Chain (Long Chain Collagen or COL7A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Collagen Alpha 1(VII) Chain (Long Chain Collagen or COL7A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Collagen Alpha 1(VII) Chain (...

May 2022 39 pages

Colon Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Colon Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Colon Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 62 pages

Community-Acquired Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Community-Acquired Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Community-Acquired Bacterial Pneumonia Drugs in Development by Stages, Ta...

May 2022 40 pages

Complement C1q Subcomponent Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Complement C1q Subcomponent Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Complement C1q Subcomponent Drugs in Development by Therapy A...

May 2022 36 pages

Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 41 pages

Complement C3 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 1 or C3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Complement C3 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 1 or C3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY C...

May 2022 52 pages

Complement Factor B (Glycine Rich Beta Glycoprotein or C3-C5 Convertase or Properdin Factor B or PBF2 or CFB or EC 3.4.21.47) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Complement Factor B (Glycine Rich Beta Glycoprotein or C3-C5 Convertase or Properdin Factor B or PBF2 or CFB or EC 3.4.21.47) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, M...

May 2022 38 pages

Complement Factor D (C3 Convertase Activator or Adipsin or Properdin Factor D or CFD or EC 3.4.21.46) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Complement Factor D (C3 Convertase Activator or Adipsin or Properdin Factor D or CFD or EC 3.4.21.46) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Pla...

May 2022 47 pages

Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 37 pages

Complicated Intra-Abdominal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Complicated Intra-Abdominal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Complicated Intra-Abdominal Infections Drugs in Development by Stages, Ta...

May 2022 56 pages

Complicated Skin and Skin Structure Infections (cSSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Complicated Skin and Skin Structure Infections (cSSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Complicated Skin And Skin Structure Infections (cSSSI) Dr...

May 2022 35 pages

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Congenital Adrenal Hyperplasia (Adrenogenital Syndrome)...

May 2022 36 pages

Congenital Ichthyosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Congenital Ichthyosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Congenital Ichthyosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 42 pages

Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 95 pages

Constipation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Constipation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Constipation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 56 pages

Copper Transporting ATPase 2 (Copper Pump 2 or Wilson Disease Associated Protein or ATP7B or EC 7.2.2.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Copper Transporting ATPase 2 (Copper Pump 2 or Wilson Disease Associated Protein or ATP7B or EC 7.2.2.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 36 pages

Corneal Graft Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Corneal Graft Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Corneal Graft Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 37 pages

Coronary Artery Disease (CAD) (Ischemic Heart Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Coronary Artery Disease (CAD) (Ischemic Heart Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Coronary Artery Disease (CAD) (Ischemic Heart Disease) Dr...

May 2022 91 pages

Corrosive Esophagitis (Erosive Esophagitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Corrosive Esophagitis (Erosive Esophagitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Corrosive Esophagitis (Erosive Esophagitis) Drugs in Development by...

May 2022 36 pages

Corticobasal Degeneration (CBD-CBGD-Cortical Basal Ganglionic Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Corticobasal Degeneration (CBD-CBGD-Cortical Basal Ganglionic Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Corticobasal Degeneration (CBD/CBGD/...

May 2022 36 pages

Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing Hormone Receptor 1 or CRHR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing Hormone Receptor 1 or CRHR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players S...

May 2022 37 pages

CREB Binding Protein (CREBBP or EC 2.3.1.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

CREB Binding Protein (CREBBP or EC 2.3.1.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY CREB Binding Protein (CREBBP or EC 2.3.1.48)...

May 2022 44 pages

Creutzfeldt Jakob Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Creutzfeldt Jakob Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Creutzfeldt Jakob Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 38 pages

Crimean-Congo Hemorrhagic Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Crimean-Congo Hemorrhagic Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Crimean-Congo Hemorrhagic Fever Drugs in Development by Stages, Target, MoA, RoA...

May 2022 38 pages

Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Cruzipain (Major Cystein...

May 2022 35 pages

Cryptococcal Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Cryptococcal Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cryptococcal Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 39 pages

Cushings Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Cushings Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cushing's Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pla...

May 2022 42 pages

Cutaneous Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Cutaneous Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cutaneous Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 47 pages

Cutaneous T-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Cutaneous T-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cutaneous T-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 125 pages

Cyclic GMP-AMP Synthase (23-cGAMP Synthase or Mab 21 Domain Containing Protein 1 or CGAS or EC 2.7.7.86) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Cyclic GMP-AMP Synthase (23-cGAMP Synthase or Mab 21 Domain Containing Protein 1 or CGAS or EC 2.7.7.86) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 38 pages

Cyclin Dependent Kinase (CDK or EC 2.7.11.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 3,500.00

Cyclin Dependent Kinase (CDK or EC 2.7.11.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Cyclin Dependent Kinase (CDK or EC 2.7.11.2...

May 2022 184 pages

Cyclin Dependent Like Kinase 5 (Serine-Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Cyclin Dependent Like Kinase 5 (Serine-Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1) Drugs in Development by The...

May 2022 36 pages

Cystine-Glutamate Transporter (Amino Acid Transport System Xc or Calcium Channel Blocker Resistance Protein CCBR1 or Solute Carrier Family 7 Member 11 or xCT or SLC7A11) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Cystine-Glutamate Transporter (Amino Acid Transport System Xc or Calcium Channel Blocker Resistance Protein CCBR1 or Solute Carrier Family 7 Member 11 or xCT or SLC7A11) Drugs in Development by Therap...

May 2022 36 pages

Cystinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Cystinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cystinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 38 pages

Cytokine Receptor Common Subunit Gamma (Interleukin 2 Receptor Subunit Gamma or GammaC or p64 or CD132 or IL2RG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Cytokine Receptor Common Subunit Gamma (Interleukin 2 Receptor Subunit Gamma or GammaC or p64 or CD132 or IL2RG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...

May 2022 51 pages

Cytokine Release Syndrome (Cytokine Storm) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Cytokine Release Syndrome (Cytokine Storm) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cytokine Release Syndrome (Cytokine Storm) Drugs in Development by St...

May 2022 48 pages

Cytopenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Cytopenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cytopenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 116 pages

Cytosolic Phospholipase A2 (Phospholipase A2 Group IVA or PLA2G4A or EC 3.1.1.4 or EC 3.1.1.5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Cytosolic Phospholipase A2 (Phospholipase A2 Group IVA or PLA2G4A or EC 3.1.1.4 or EC 3.1.1.5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SU...

May 2022 41 pages

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 113 pages

D Amino Acid Oxidase (DAAO or DAMOX or DAO or EC 1.4.3.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

D Amino Acid Oxidase (DAAO or DAMOX or DAO or EC 1.4.3.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY D Amino Acid Oxidase (DAAO or D...

May 2022 35 pages

D1A Dopamine Receptor (Dopamine D1 Receptor or DRD1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

D1A Dopamine Receptor (Dopamine D1 Receptor or DRD1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY D1A Dopamine Receptor (Dopamine D1 R...

May 2022 66 pages

D1B Dopamine Receptor (D5 Dopamine Receptor or D1 Beta Dopamine Receptor or Dopamine D5 Receptor or DRD5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

D1B Dopamine Receptor (D5 Dopamine Receptor or D1 Beta Dopamine Receptor or Dopamine D5 Receptor or DRD5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 45 pages

D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 3,500.00

D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY D2 Dopamine Receptor (Dopamine D2 Rec...

May 2022 140 pages

D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY D3 Dopamine Receptor (Dopamine D3 Rec...

May 2022 83 pages

D4 Dopamine Receptor (D2C Dopamine Receptor or Dopamine D4 Receptor or DRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

 US$ 2,500.00

D4 Dopamine Receptor (D2C Dopamine Receptor or Dopamine D4 Receptor or DRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY D4 Dopamine...

May 2022 51 pages

Dedifferentiated Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

 US$ 2,000.00

Dedifferentiated Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Dedifferentiated Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 51 pages

Filters

Clear all

Search

Categories

836
28
208
156
143
133
127
93
65,439
803
718
772
123

Publishers

179
1
239
158
389
103
444
148
425
3
202
3
6
1,620
487
76
123
208
111
25
212
1,049
378
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,790
60
1,696
8
8,921
2,212
4,495
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
323
8
3
18
58
901
6
89
12
24
15
1,285
227
128
386
3
74
10
119
228
46
474
26
133
4

Regions

92
58
45
43
41
35
31
30
30
29
28
28
28
26
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
790
495
2
2
2
117
194
102
53
23
704
26
136
526
174
623
64,568

Price

—

Date

—

Pages

—

Offers

1
280
1
1